Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFORMS: Fingolimod vs Placebo in Primary Progressive Multiple Sclerosis
NCT00731692Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jul 2008
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of fingolimod in primary progressive multiple sclerosis (PPMS), sponsored by Novartis. Started Jul 2008; status: terminated.
02
Drugs
fingolimod
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT00731692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731692.